The financial terms of the deal were not disclosed.
Korsch said Medelpharm’s compaction simulator technology adds early-stage material characterization and scale-up capability to its R&D product portfolio.
The companies have 135-plus years of experience with small-scale, fully instrumented tablet compression equipment. The Korsch R&D product portfolio addresses and overcomes longstanding challenges, from early-stage powder characterization and formulation development, to predictive scale-up and production support.
The combined Korsch-Medelpharm R&D equipment lineup includes:XP 1: Robust single-punch tablet press with small batch capabilities; STYL’One Nano: Benchtop compaction simulator…